| Oct 21 |
Thermo Fisher’s Oncomine gains FDA approval as brain tumor diagnostic
|
| Oct 18 |
Thermo Fisher Scientific (TMO): Resilient Performance Despite Revenue Dip
|
| Oct 18 |
UBS upgrades view on U.S. stocks to attractive - here are its top picks
|
| Oct 18 |
Thermo Fisher (TMO) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
|
| Oct 17 |
Integer (ITGR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
|
| Oct 16 |
Thermo Fisher Scientific (TMO) Expected to Beat Earnings Estimates: Should You Buy?
|
| Oct 15 |
Should ISRG Stock Be Part of Your Portfolio Ahead of Q3 Earnings?
|
| Oct 14 |
Robust Analytical Instrument Segment Likely to Aid TMO's Q3 Earnings
|
| Oct 11 |
Running on Ice: Big things coming in smaller pharma packages
|
| Oct 11 |
MYGN Taps Ultima Genomics' UG 100 Platform for Advanced Clinical Tests
|
